J J Doyle
- A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAsJ J Doyle
Columbia University, School of Public Health, New York, NY, USA
Value Health 4:16-31. 2001..A policy analysis was conducted to examine the health system budget impact in each country of increasing the utilization of the most effective antidepressant found in our study...
- A cost-effectiveness evaluation of amlodipine usage in patients with coronary artery disease in SwedenJ J Doyle
The Analytica Group, New York, NY 10016, USA
Int J Clin Pract 56:76-81. 2002..9%. The cost per patient was Swedish kroner (SEK)26,600 for amlodipine patients and SEK27,400 for placebo patients. The use of amlodipine resulted in improved clinical outcomes as well as a slight savings in cost over a three-year period...